Colorectal Cancer

2 targeted drugs for treatment of the KRAS mutations cancer

There have been several targeted therapies under development for the treatment of cancers with KRAS mutations. Sotorasib[1] One of the most promising targeted therapies for KRAS-mutant cancers is sotorasib (also known as AMG 510). Sotorasib specifically targets the KRAS G12C mutation, which is found in a subset of non-small cell…